Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Subsequent Events (Details Textual)

v3.20.2
Note 13 - Subsequent Events (Details Textual) - Changzhou Eminence Biotechnology [Member] - Subsequent Event [Member]
$ in Millions
Oct. 20, 2020
USD ($)
Business Acquisition, Percentage of Voting Interests Acquired 47.60%
Business Combination, Consideration Transferred, Total $ 10